China Universal Asset Management Co., Ltd. Tyra Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 10,150 shares of TYRA stock, worth $107,691. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,150
Previous 10,730
5.41%
Holding current value
$107,691
Previous $149,000
36.91%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$113 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$44 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$43.3 Million90.83% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$43 Million8.77% of portfolio
-
Nextech Invest Ag4.06MShares$43 Million10.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $445M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...